title: The clinical benefit of cardiac resynchronization therapy optimization using a device-based hemodynamic sensor in a patient with dilated cardiomyopathy: a case report.
abstract: BACKGROUND
  Results on the evolution of the clinical status of patients undergoing cardiac resynchronization therapy with a defibrillator after automatic optimization of their cardiac resynchronization therapy are scarce. We observed a rapid and important change in the clinical status of our non-responding patient following activation of a sensor capable of weekly atrioventricular and interventricular delays' optimization.
  
  
  METHODS
  A 78-year-old Caucasian man presented with dilated cardiomyopathy, left bundle branch block, a left ventricular ejection fraction of 35 %, New York Heart Association class III/IV heart failure, and paroxysmal atrial fibrillation. Our patient was implanted with a cardiac resynchronization device with a defibrillator and the SonRtip atrial lead. Right ventricular and left ventricular leads were also implanted. Because of the recurrence of atrial fibrillation, the automatic optimization was set off at discharge. Consequently, the device did not optimize atrioventricular and interventricular delays (programming at discharge: 125 ms for the atrioventricular delay and 0 ms for the interventriculardelay). Our patient was treated with an anti-arrhythmic drug. Five months after implantation, his clinical status remained impaired (left ventricular ejection fraction = 30 %). The SonR signal amplitude had also decreased from 0.52 g to 0.29 g. Nevertheless, because our patient was no longer presenting with atrial fibrillation, the anti-arrhythmic treatment was stopped and the SonR optimization system was activated. After 2 months of automatic cardiac resynchronization therapy with defibrillator optimization, our patient's clinical status had significantly improved (left ventricular ejection fraction = 60 %, New York Heart Association class II) and the SonR signal amplitude had doubled shortly after the first weekly automatic optimization.
  
  
  CONCLUSIONS
  In this non-responding patient, device-based automatic cardiac resynchronization therapy optimization was shown to significantly improve his clinical status.
authors.affiliation: H. San Giovanni Bosco, Naples, Italy. mariovolp@alice.it.
authors.forename: Mario
authors.initials: M
authors.lastname: Volpicelli
authors.affiliation: H. San Giovanni Bosco, Naples, Italy. gregoriocovino@libero.it.
authors.forename: Gregorio
authors.initials: G
authors.lastname: Covino
authors.affiliation: H. San Giovanni Bosco, Naples, Italy. paolocapogrosso@tin.it.
authors.forename: Paolo
authors.initials: P
authors.lastname: Capogrosso
mesh_terms: D000368:Aged; D002037:Bundle-Branch Block / Q000503:physiopathology / Q000628:therapy*; D058406:Cardiac Resynchronization Therapy; D002311:Cardiomyopathy, Dilated / Q000503:physiopathology / Q000628:therapy*; D004562:Electrocardiography; D006439:Hemodynamics; D006801:Humans; D008297:Male; D018570:Risk Assessment; D016896:Treatment Outcome